Cyproheptadine Hydrochloride Tablet
Product Images NDC 70752-107

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 70752-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quagen Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Chemsture)

Chemical structure of cyproheptadine hydrochloride, showing its molecular formula (C21H21N·HCl) and molecular weight (350.89). The diagram illustrates the compound's ring and side-chain structure.*

FDA Label Image

Principal Display Panel (1000 Tablets Bottle Label)

Label for Cyproheptadine HCl Tablets, USP 4 mg by Quagen Pharmaceuticals LLC. The label indicates a package containing 1000 tablets for oral use. It includes storage instructions, dosage reference to package insert, and child-resistant closure warning. Manufactured in West Caldwell, NJ, USA.*

FDA Label Image

Principal Display Panel (100 Tablets Bottle Label)

Cyproheptadine HCl Tablets, USP 4 mg oral tablets in a carton from Quagen Pharmaceuticals LLC. The package contains 100 tablets, marked Rx Only, with storage instructions and a barcode. The label includes the NDC number 70752-107-10 and highlights child-resistant container packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.